M6PT translates advanced science into best-in-class therapies that address unmet needs within the LSD community.
M6PT is focused on developing next generation enzyme replacement and gene therapies for LSDs.
M6PT has developed the only technology that enables substantially improved cellular uptake of therapeutic enzymes into key target cells.
M6PT is deeply committed to individuals and communities affected by LSDs and delivering meaningful therapies.
20 S. Sarah StreetSt. Louis, MO 63108